Sickle Cell Anemia Testing & Screening Market Research Report by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), and Point-of-Care Tests), by Age Group (Adult Screening (25 to 60 years), Newborn Screening (12 months and below), and Other Age Groups (1 to 25 & above 60 years)), by Sector, by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19
The United States Sickle Cell Anemia Testing & Screening Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Sickle Cell Anemia Testing & Screening Market.
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage: This research report categorizes the Sickle Cell Anemia Testing & Screening to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the Sickle Cell Anemia Testing & Screening Market was studied across Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), and Point-of-Care Tests. The Hemoglobin Electrophoresis is further studied across Isoelectric focusing. The Point-of-Care Tests is further studied across Lateral Flow Immunoassay and Paper Based Rapid Diagnostics.
Based on Age Group, the Sickle Cell Anemia Testing & Screening Market was studied across Adult Screening (25 to 60 years), Newborn Screening (12 months and below), and Other Age Groups (1 to 25 & above 60 years).
Based on Sector, the Sickle Cell Anemia Testing & Screening Market was studied across Corporate Labs, Government Labs, PPP (Public-Private-Partnerships), and Private Labs.
Based on Geography, the Sickle Cell Anemia Testing & Screening Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Sickle Cell Anemia Testing & Screening Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as: 1. What is the market size and forecast of the United States Sickle Cell Anemia Testing & Screening Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the United States Sickle Cell Anemia Testing & Screening Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Sickle Cell Anemia Testing & Screening Market? 4. What is the competitive strategic window for opportunities in the United States Sickle Cell Anemia Testing & Screening Market? 5. What are the technology trends and regulatory frameworks in the United States Sickle Cell Anemia Testing & Screening Market? 6. What is the market share of the leading vendors in the United States Sickle Cell Anemia Testing & Screening Market? 7. What modes and strategic moves are considered suitable for entering the United States Sickle Cell Anemia Testing & Screening Market?
Our reports have been used by over 10K customers, including:
278 pages •
By Global Industry Analysts
• Apr 2021
- Global Anatomic Pathology Market to Reach $26.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Anatomic Pathology estimated at US$18.7 Billion in the year 2020, is projected to reach a revised size of US$26.3 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027....
573 pages •
By Global Industry Analysts
• Apr 2021
- Looking Beyond Today’s Challenges to Tomorrow’s Healthcare Needs. Genetic Testing to Reach $18.9 Billion as the Burden of Non-Communicable Diseases Grows Bigger
- The global market for Genetic Testing is forecast to reach US$18.9 billion by the year 2027, trailing a post COVID-19 CAGR of 8.6% over the...
185 pages •
By Global Industry Analysts
• Apr 2021
- Global Pathology Instruments Market to Reach $4.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Pathology Instruments estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027....
200 pages •
By The Business Research Company
• Mar 2021
Major players in the ultra-low temperature freezers market are Arctiko, Eppendorf, Esco Micro Pte Ltd, Haier, Helmer Scientific, Bionics Scientific Technologies (P). Ltd, PHC Holdings Corporation, Labcold Ltd, Remi Group, and Stirling Ultracold. The global ultra-low temperature freezers market is expected to decline from $633.94 million...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
Patient history: The industry will likely benefit from new-and-improved service capability advances Abstract Diagnostic & Medical Laboratories in the US Operators in the Diagnostic and Medical Laboratories industry are an integral part of patients’ medical evaluation and treatment. Laboratories are...
Strong arch: As the unemployment rate declines, the industry’s customer base will grow Abstract Eyebrow Services in the USOperators in this industry are primarily engaged in threading, waxing or otherwise servicing eyebrows. Hair and nail salons are not included in this industry. This report covers...
Step by step: An aging US population and a rising prevalence of diabetes are expected to boost industry demand Abstract Podiatrists in the US Over the five years to 2019, the Podiatrists industry has stepped in the right direction. Revenue growth has been supported by the aging US population and the...
Melanoma - Global Drug Forecast and Market Analysis to 2029
Melanoma of the skin is a serious and aggressive form of cancer originating from melanocytes, the pigment cells in skin, and can develop anywhere on the body.Although melanoma has high survivability, it remains a significant health...
Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products.The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies...
In Vitro Diagnostic Reagent
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.